Galdu-irabazien kontua
ATOSSA THERAPEUTICS, INC.
ATOS
Errendimenduaren laburpena
Egin klik taulako edozein lerrotan grafikoan gehitzeko
milioika USDtan
| Neurria | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY | Dec 31, 2020 2020 FY | Dec 31, 2019 2019 FY | Dec 31, 2018 2018 FY | Dec 31, 2017 2017 FY | Dec 31, 2016 2016 FY | Dec 31, 2015 2015 FY | Dec 31, 2014 2014 FY | Dec 31, 2013 2013 FY | Dec 31, 2012 2012 FY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Diru-sarrerak
|
- | - | - | - | - | - | - | - | - | - | 0.00 | 0.53 | 0.63 | 0.48 |
|
Diru-sarreren kostua
|
- | - | - | - | - | - | - | - | - | 0.00 | 0.13 | 0.34 | 0.35 | 0.04 |
|
Irabazi gordina
|
- | - | - | - | - | - | - | - | - | - | -0.13 | 0.19 | 0.14 | 0.42 |
|
Ustiapen-gastuak
|
37.14 | 27.62 | 31.38 | 27.69 | 20.52 | 14.61 | 17.27 | 11.43 | 7.65 | 7.97 | 12.63 | 14.83 | 10.92 | 5.49 |
|
Ikerketa eta garapena
|
21.19 | 14.12 | 17.33 | 15.08 | 9.21 | 6.61 | 6.65 | 4.21 | 2.33 | 0.77 | 2.36 | 2.58 | 1.11 | - |
|
Salmentak, orokorrak eta administratiboak
|
15.96 | 13.50 | 14.04 | 12.61 | 11.31 | 8.00 | 10.62 | 7.22 | 4.86 | 6.48 | 8.85 | 8.63 | 8.56 | 5.02 |
|
Beste ustiapen-gastu batzuk
|
- | - | - | - | - | - | - | - | - | - | - | - | - | - |
|
Ustiapen-irabaziak
|
-37.14 | -27.62 | -31.38 | -27.69 | -20.52 | -14.61 | -17.27 | -11.43 | -7.65 | -7.97 | -12.76 | -14.64 | -10.78 | -5.07 |
|
Ez-ustiapeneko diru-sarrerak
|
-2.37 | -2.12 | -1.28 | -0.73 | 0.09 | 3.22 | -0.03 | -0.03 | 0.00 | 1.60 | 0.00 | 0.02 | 0.00 | 0.01 |
|
Interesen diru-sarrerak
|
2.38 | 4.05 | 4.34 | 0.88 | - | - | - | - | - | - | - | 0.00 | 0.00 | 0.00 |
|
Interesen gastuak
|
- | - | - | - | - | - | - | - | - | - | - | 0.02 | 0.00 | 0.01 |
|
Beste ez-ustiapeneko diru-sarrerak/gastuak
|
-0.01 | -0.22 | -0.07 | -0.15 | -0.09 | 0.05 | 0.03 | 0.03 | - | - | - | - | - | - |
|
Zerga aurreko irabazia
|
-34.77 | -25.50 | -30.09 | -26.96 | -20.61 | -17.83 | -17.24 | -11.40 | -8.12 | -6.37 | -12.76 | -14.66 | -10.78 | -5.08 |
|
Zerga-gastua
|
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 3.00 | 0.00 | 0.00 | 0.00 |
|
Partaidetza ez-kontrolatzailea
|
- | - | - | - | - | - | - | - | - | - | - | - | - | - |
|
Irabazi garbia
|
-34.77 | -25.50 | -30.09 | -26.96 | -20.61 | -17.83 | 17.24 | 11.40 | -8.12 | -6.37 | -15.76 | -14.66 | -10.78 | -5.08 |
Informazio osagarria
Akzioko datuak, eratorritakoak eta bestelakoak — ez dira galdu-irabazien kontuaren parte
milioika USDtan, bestela adierazi ezean
| Neurria | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY | Dec 31, 2020 2020 FY | Dec 31, 2019 2019 FY | Dec 31, 2018 2018 FY | Dec 31, 2017 2017 FY | Dec 31, 2016 2016 FY | Dec 31, 2015 2015 FY | Dec 31, 2014 2014 FY | Dec 31, 2013 2013 FY | Dec 31, 2012 2012 FY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Amortizazioa eta balio-galera
|
- | - | - | - | - | - | - | - | - | - | - | - | - | - |
|
EBITDA
|
-37.14 | -27.62 | -31.38 | -27.68 | -20.50 | -14.56 | -17.21 | -11.39 | -7.52 | -7.67 | -12.49 | -14.08 | -10.31 | -4.94 |
|
Akzioko irabazia (oinarrizkoa)
|
-4.04 | -0.20 | -0.24 | -0.21 | - | - | - | - | - | - | - | - | - | - |
|
EPS diluitua
|
-4.04 | -0.20 | -0.24 | - | - | - | - | - | - | - | - | - | - | - |
|
Akzioen batez besteko haztatua
|
8.61 | 125.86 | 126.08 | 126.62 | - | - | - | - | - | - | - | - | - | - |
|
Akzioen batez besteko haztatu diluitua
|
8.61 | 125.86 | 126.08 | - | - | - | - | - | - | - | - | - | - | - |
|
Irabazi globala
|
- | - | - | - | - | - | - | - | - | - | - | - | - | - |